Farmacia hospitalaria

2024

1. Acetazolamide-induced pulmonary oedema: A disproportionality analysis from the EudraVigilance database

   British Journal of Clinical Pharmacology, Vol. 90, Núm. 7, pp. 1751-1755

2. Analysis 2016-2021 of the development of the MAPEX outpatient pharmaceutical care Project by regions in Spain

   Farmacia Hospitalaria, Vol. 48, Núm. 2, pp. 64-69

3. Analysis of the evolution of outpatient pharmaceutical care in hospital pharmacy services in Spain after the implementation and development of the MAPEX initiative

   Journal of Healthcare Quality Research, Vol. 39, Núm. 2, pp. 65-79

4. Analysis of the situation of pharmaceutical care for patients with immune-mediated inflammatory diseases before and after the COVID-19 pandemic

   Farmacia Hospitalaria

5. Astrocyte S100β expression and selective differentiation to GFAP and GS in the entorhinal cortex during ageing in the 3xTg-Alzheimer's disease mouse model

   Acta Histochemica, Vol. 126, Núm. 1

6. Biosimilars and access to biologic therapy in immune-mediated diseases

   Expert Opinion on Biological Therapy, Vol. 24, Núm. 7, pp. 647-653

7. De-imFAR phase II project: a study protocol for a cluster randomised implementation trial to evaluate the effectiveness of de-implementation strategies to reduce low-value statin prescribing in the primary prevention of cardiovascular disease

   BMJ Open, Vol. 14, Núm. 4

8. Elimination of hepatitis C virus in a prison: An 18-year experience

   Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 5, pp. 236-241

9. Evaluation of the safety of medication-use systems in hospital emergency services

   Farmacia Hospitalaria

10. GEDEFO-SEFH management of antineoplastic extravasations survey results

    Journal of Oncology Pharmacy Practice, Vol. 30, Núm. 1, pp. 67-77

11. Galunisertib downregulates mutant type I collagen expression and promotes MSCs osteogenesis in pediatric osteogenesis imperfecta

    Biomedicine and Pharmacotherapy, Vol. 175

12. Intranasal esketamine and manic symptoms: A disproportionality analysis in EudraVigilance

    European Neuropsychopharmacology

13. Kimioterapiaren ondorengo anemiaren eta sukar-neutropeniaren maneiua

    Osagaiz: osasun-zientzien aldizkaria, Vol. 8, Núm. 1, pp. 101-106

14. Ospitaleko farmazialariaren eta medikuaren arteko elkarlana GIBa duten pazienteen tratamenduen eraginkortasuna eta segurtasuna bermatzeko

    Osagaiz: osasun-zientzien aldizkaria, Vol. 8, Núm. 1, pp. 51-58

15. Use of rasburicase to improve kidney function in children with hyperuricemia and acute kidney injury

    Clinical and Experimental Nephrology, Vol. 28, Núm. 1, pp. 13-22

16. [Translated article] Analysis 2016-2021 of the development of the MAPEX outpatient pharmaceutical care Project by Regions in Spain

    Farmacia Hospitalaria, Vol. 48, Núm. 2, pp. T64-T69

17. [Translated article] Pharmaceuticals in the environment: A hospital pharmacy perspective

    Farmacia Hospitalaria, Vol. 48, pp. TS13-TS20